Society of Nuclear Medicine
Corporate donors have given the Society of Nuclear Medicine of Reston, Va., nearly $3.3 million for its Bench to Bedside campaign, a five-year effort to raise $5 million for molecular imaging research. The sum includes more than $1 million from IBA Molecular of Sterling, Va., MDS Nordion of Ottawa and Cardinal Health of Dublin, Ohio. Previous donations from GE Healthcare of Chalfont St. Giles, UK, Bristol-Myers Squibb Medical Imaging of Princeton, N.J., Siemens Medical Solutions USA of Malvern, Pa., Royal Philips Electronics N.V. of Amsterdam and FluoroPharma Inc. of Boston make up the remainder of the gift. The society is carrying out the campaign in cooperation with its Education and Research Foundation. Together with representatives from its Molecular Imaging Center of Excellence, the organization has decided that funds from the initiative will be applied to translational research as well as clinical research and trials, with the goal of developing molecular imaging technologies for more individualized patient treatment. The money also will be used to support outreach activities to referring physicians, patient groups and others, and to help train individuals in the use of imaging applications.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024